Spleen capture of nanoparticles: Influence of animal species and surface characteristics

Pharmaceutical Research

Volumn 16, Issue 1, 1999, Pages 37-41

  Demoy, Marina ^a   Andreux, Jean Paul ^b   Weingarten, Colette ^a   Gouritin, Bruno ^b   Guilloux, Valérie ^b   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Mouse; Nanoparticles; Quantification; Spleen; Surfactants; Targeting

Indexed keywords

ESTAPOR; FLUORESBRITE; NANOPARTICLE; POLYSTYRENE; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; DRUG COATING; DRUG DISTRIBUTION; DRUG TARGETING; FLUOROMETRY; IMAGE ANALYSIS; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; SPLEEN CELL; SURFACE PROPERTY;

ANIMALS; ETHYLENEDIAMINES; FLUOROMETRY; MICE; MICROCHEMISTRY; PARTICLE SIZE; POLOXAMER; POLYETHYLENE GLYCOLS; RATS; SOLUBILITY; SPECIES SPECIFICITY; SPLEEN; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; WATER;

EID: 0032930320     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018858409737     Document Type: Article

References (15)

1. Y. Arakami, K. Akiyama, T. Hara, and S. Tsuchiya. Recognition of charged liposomes by rat peritoneal macrophages: effects of fibronectin on the uptake of charged liposomes. Eur. J. Pharm. Sci. 3:63-70 (1995).
2. 1 accumulate effectively in spleen. Biochem. Biophys. Acta 1066:159-165 (1991).
3. S. S. Davis, L. Illum, S. M. Moghimi, C. J. H. Porter, A. Muir, A. Brindley, N. M. Christy, M. E. Norman, P. Williams, and S. E. Dunn. Microspheres for targeting drugs to specific body sites. J. Contr. Rel. 24:157-163 (1993).
4. S. M. Moghimi. Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents. Adv. Drug Del. Rev. 17:103-115 (1995).
5. S. M. Moghimi, C. J. Porter, I. S. Muir, L. Illum, and S. S. Davis. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coatings. Biochem. Biophys. Res. Commun. 177(2):861-866 (1991).
6. S. M. Moghimi, H. Hedeman, L. Illum, and S. S. Davis. Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres. Clin. Sci. 84:605-609 (1993).
7. S. M. Moghimi, H. Hedeman, I. S. Muir, L. Illum, and S. S. Davis. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in the rat spleen. Biophys. Biochem. Acta 1157:233-240 (1993).
8. C. J. Porter, S. M. Moghimi, L. Illum, and S. S. Davis. The polyoxyethylene/polyoxypropylene block co-polymer selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett. 305:62-66 (1992).
9. L. Illum, S. S. Davis, R. H. Müller, E. Mak, and P. West. The organ distribution and circulation tissue of intravenously injected colloïdal carriers sterically stabilized with a block co-polymer: poloxamine 908. Life Sci. 40:367-374 (1987).
10. S. M. Moghimi. Poloxamer 188 revisited: a potentially valuable immune modulator. J. Nat. Cancer Inst. 88:766-768 (1996).
11. S. M. Moghimi, H. Hedeman, N. M. Christy, L. Illum, and S. S. Davis. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymozan-stimulated rats. J. Leuk. Biol. 54:513-517 (1993).
12. R. H. Müller, and K. H. Wallis. Surface modification of I.V. injectable biodegradable nanoparticles with poloxamers polymers and poloxamine 908. Int. J. Pharm. 89:25-31 (1993).
13. M. Demoy, S. Gibaud, J. P. Andreux, C. Weingarten, B. Gouritin, and P. Couvreur. Splenic trapping of nanoparticles: complementary approaches for in situ studies. Pharm. Res. 14:463-468 (1997).
14. L. Weiss. Mechanisms of splenic clearance of the blood; a structural overview of the mammalian spleen. In: A. J. Bowdler (ed), The spleen: structure, function and clinical significance. Chapman and Hall, London, 1990, pp. 25-35.
15. R. H. Müller, D. Rühl, M. Lück, and B. R. Paulke. Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity and plasma protein adsorption. Pharm. Res. 14:18-24 (1997).